PH vs SUPN · P/E 28, rev $19.85B vs rev $661.8M
Parker-Hannifin Corporation (PH) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Latest reported SUPN revenue for 2024-12-31 was $661.8M. Net income was $73.9M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. SUPN currently screens at market cap $2.53B.
PH currently screens at market cap $91.89B and trailing P/E 27.7. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the PH and SUPN stock pages for the full models.
Not investment advice.